Technique of retinal gene therapy: delivery of viral vector into the subretinal space – (Eye 31, 1308 (September 2017))
Technique of retinal gene therapy: delivery of viral vector into the subretinal space Eye 31, 1308 (September 2017). doi:10.1038/eye.2017.158 Authors: K Xue, M Groppe, A P Salvetti & R E MacLaren
Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy – (Eye 31, 1317 (September 2017))
Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy Eye 31, 1317 (September 2017). doi:10.1038/eye.2017.21 Authors: B N M K Khanum, R Guha, V P Sur, S Nandi, S K Basak, A Konar & S Hazra
Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the way forward? Yes – (Eye 31, 1329 (September 2017))
Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the way forward? Yes Eye 31, 1329 (September 2017). doi:10.1038/eye.2017.52 Authors: V S Liarakos, M Tsatsos, M Satue & G R J Melles
Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the Holy Grail of lamellar surgery? No – (Eye 31, 1333 (September 2017))
Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the Holy Grail of lamellar surgery? No Eye 31, 1333 (September 2017). doi:10.1038/eye.2017.51 Authors: M Tsatsos, V S Liarakos, C MacGregor, I Athanasiadis, E T Detorakis, M M Moschos, P Hossain & D F Anderson
A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab – (Eye 31, 1337 (September 2017))
A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab Eye 31, 1337 (September 2017). doi:10.1038/eye.2017.67 Authors: S R Rufai, H Almuhtaseb, R M Paul, B L Stuart, T Kendrick, H Lee & A J Lotery